Maruho Report 2023
29/60

Maruho Report 2023281.Maruho’s Meaning of ExistenceAs these results show, Maruho’s strength is not in providing uniform information on individual products, but in providing a variety of information according to the characteristics of the region, such as the patient’s background and medical situation. In the future, we will further deepen our strengths in activities that meet the true needs of patients and medical care, as well as in each specialized function such as sales, marketing, and medical.From pre-illness to diagnosis, treatment, prevention, and aftercare, we will ensure that we are in tune with each individual’s skin problems at every stage of life, build a system to solve these problems, and expand the scope of our contributions to self-care. We will also focus on creating a system to support patients when they undergo a medical consultation and enhancing disease information sites for patients with the aim of disseminating information on appropriate use that is easy to convey to patients.We will evolve our provision of information according to the characteristics of each region to increase added 2.Value Creation Prospects3.Strategy for Value Creation4.Foundation for Sustainable Growthvalue unique to Maruho. Skin Disease Regional Leaders will play a central role in collaborating with internal and external networks to help us establish a high level of expertise and problem-solving capabilities. We plan to strengthen our focus areas, while clarifying the division of functions in fields, areas, and digital.In addition to these, we will leverage synergies with the diagnostics, medical devices, and cosmetics businesses and collaboration with external partners to build a dermatology platform to connect with individuals facing skin problems. Through this platform, we intend to provide new awareness and experiences to medical professionals and all people facing skin problems. At the same time, we will further strengthen our digital information provision system and enhance content that enables us to connect with patients.Based on the above approaches, from the fiscal year ending September 2024, we will efficiently allocate resources to new drug fostering and evolution as well as ensure the growth trend of the domestic prescription drug business remains intact. In our information provision activities, Skin Disease Regional Leaders will play a central role in providing custom-made information according to the background of each patient and the characteristics of the region by making the most of digital technology.5.Financial/ Company InformationSpecialty website supporting people to clear up their acneAssessment of the fiscal year ended September 2023Contributed to acne treatment with unique information provision based on regional characteristicsIn the fiscal year ended September 2023, we conducted a wide range of activities to raise disease awareness for patients (area DTC), and achieved significant results in providing high-quality information that reflects the voices of patients. To solve the problems of acne patients, we identified the characteristics of each region based on open data and analysis results of each information provision channel. This is an initiative unique to Maruho, which continues to listen to the voices of acne patients. We discuss the information we obtain with dermatologists to contribute to solving acne problems.Plan for the fiscal year ending September 2024 and beyondAiming for information gathering and provision closely in tune with skin issuesWe will implement the following initiatives under the Fifth Medium-Term Plan.In order to truly address skin concerns, each and every one of our employees must be able to communicate information to medical professionals and patients in their own words. We will create a work environment where employees can improve each other while developing autonomous and motivated human resources. Additionally, we will strengthen the system for sharing information and making recommendations within the company. At the same time, we will also use digital technology to increase the efficiency of information provision activities and the accuracy of analysis of collected information. As a leading company in dermatology, we will continue to promote the Maruho brand and contribute to advancements in medical care and society.Takashi KitagawaJapan Business OperationsEmpowering each and every employee to disseminate information in their own words

元のページ  ../index.html#29

このブックを見る